Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial By: CNBC.com News June 20, 2024 at 11:22 AM EDT Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial By: CNBC.com News June 20, 2024 at 11:22 AM EDT Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. Read More >>